title: Reply to Karch et al.
authors.forename: Hiroyu
authors.initials: H
authors.lastname: Hatano
authors.forename: Peter
authors.initials: P
authors.lastname: Bacchetti
authors.forename: Priscilla Y
authors.initials: PY
authors.lastname: Hsue
authors.forename: Steven G
authors.initials: SG
authors.lastname: Deeks
mesh_terms: D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism*; D015658:HIV Infections / Q000188:drug therapy*; D019428:HIV Integrase Inhibitors / Q000008:administration & dosage*; D016325:HIV Long Terminal Repeat / Q000235:genetics*; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D008297:Male; D011760:Pyrrolidinones / Q000008:administration & dosage*
chemical_list: D005338:Fibrin Fibrinogen Degradation Products; D019428:HIV Integrase Inhibitors; D011760:Pyrrolidinones